HOME >> BIOLOGY >> NEWS
New anthrax inhibitor could combat antibiotic-resistant strains

Note: This press release was updated on August 23, 2006.

Troy, N.Y. - In a new approach to treating anthrax exposure, a team of scientists has created an inhibitor designed to tackle the growing threat of antibiotic-resistant strains. Reporting in this week's online early edition of the Proceedings of the National Academy of Sciences (PNAS), researchers from Rensselaer Polytechnic Institute and the University of Toronto describe the new anthrax toxin inhibitor, which performed successfully in both laboratory and animal tests.

Anthrax toxin, secreted by the anthrax bacterium, is made of proteins and toxic enzymes that bind together to inflict damage on a host organism. Rather than targeting the anthrax bacterium or toxin - the approach taken by the majority of current therapies - the new inhibitor blocks the receptors where anthrax toxin attaches in the body. And because the nanoscale assembly of molecules is designed to bind to multiple sites on the host receptor, it is naturally more potent.

The new approach led to a 50,000-fold increase in potency in cell culture, and the inhibitor protected rats from anthrax toxin in the study. The general concept also could be applied to designing inhibitors for other pathogens, including SARS, influenza, and AIDS, the researchers note.

ncreased research on possible therapeutics and vaccines to treat toxins that could be used as biological weapons. The current treatment for anthrax exposure is antibiotics, but the emergence of antibiotic-resistant strains calls for new approaches to designing therapeutics for bioterrorism agents, according to Ravi Kane, the Merck Associate Professor of Chemical and Biological Engineering at Rensselaer and corresponding author of the PNAS paper.

Pathogens such as anthrax can become resistant to antibiotics through natural processes, but resistance also can be engineered intentionally. The team's new approach co
'"/>

Contact: Jason Gorss
gorssj@rpi.edu
518-276-6098
Rensselaer Polytechnic Institute
28-Aug-2006


Page: 1 2 3

Related biology news :

1. Taming the anthrax threat
2. New finding points way to foiling anthraxs tricks
3. UGA researchers discover cell-wall carbohydrate that is crucial to anthrax bacterium
4. Combating anthrax: Results of study published this month as researchers look for a better vaccine
5. Vaccine combined with short-term postexposure antibiotics protects monkeys from inhalational anthrax
6. Patent awarded for LSUHSC-developed peptide that blocks lethal toxins of anthrax
7. Scientists design potent anthrax toxin inhibitor
8. Newly discovered protein kills anthrax bacteria by exploding their cell walls
9. Driver of anthrax toxicity could lead to late-stage therapy
10. UCSD study finds anthrax toxins also harmful to fruit flies
11. UCF, NIH study: Effective, safe anthrax vaccine can be grown in tobacco plants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/5/2017)... 4, 2017 KEY FINDINGS The ... at a CAGR of 25.76% during the forecast period ... primary factor for the growth of the stem cell ... MARKET INSIGHTS The global stem cell market ... and geography. The stem cell market of the product ...
(Date:3/30/2017)... , March 30, 2017 Trends, opportunities and ... and behavioral), by technology (fingerprint, AFIS, iris recognition, facial ... and others), by end use industry (government and law ... financial and banking, and others), and by region ( ... , Asia Pacific , and the ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):
(Date:6/22/2017)... , ... June 21, 2017 , ... ... office in North Carolina, and engages Timothy Reinhardt to manage the new site. ... leadership at Pfizer Inc, with his most recent role as the Director of ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... designating infertility as a disease, bringing new hope for prospective parents who are ... annual meeting to back the World Health Organization’s designation in hopes of changing ...
(Date:6/22/2017)... ... 2017 , ... The first human cell line HeLa, established in 1951, has ... cross-contamination of human cell lines with HeLa cells were published. Until recently, cross-contamination and ... and is associated with dramatic consequences for research. , In this educational webinar, ...
(Date:6/20/2017)... ... June 20, 2017 , ... CTNext , ... directors has formed a Higher Education Entrepreneurship Advisory Committee to implement the recommendations ... and other high-ranking representatives from 35 higher education institutions across the state over ...
Breaking Biology Technology:
Cached News: